项目基金：
1、国家自然科学基金-面上项目，82472120，起止时间：2025.01-2028.12（主持、在研）
2、国家自然科学基金-青年科学基金项目，82103404，起止时间：2022.01.01-2024.12.31（主持、在研）
3、广东省基础与应用基础研究基金联合基金-青年基金项目，2020A1515110719，起止时间：2020.10.01-2023.09.30（主持、结题）
4、广州市基础与应用基础研究专题-续航项目，2024A04J9988，起止时间：2024.01.01-2025.12.31（主持、在研）
5、广州市基础与应用基础研究项目-博士青年科技人员类，2024A04J9988，起止时间：2021.04.01-2023.03.31（主持、结题）
6、南方医科大学优青培育计划项目，2020YQPY008，起止时间：2020.04-2022.04（主持、结题）
7、南方医科大学高层次人才启动资金项目，PY2020001，起止时间：2020.04-2023.03（主持、结题）
科研论文：
1. Cui H#, Zhao YY#, Wu Q#, You Y#, Lan Z, Zou KL, Cheng GW, Chen H, Han YH, Chen Y, Qi XD, Meng XW, Ma LM*, Yu GT*, Microwave-responsive gadolinium metal-organic frameworks nanosystem for MRI-guided cancer thermotherapy and synergistic immunotherapy, Bioact Mater. 2024, 35: 532-544. (IF=18.9)
2. Yu GT#*, Zhu WX#, Zhao YY#, Cui H, Chen H, Chen Y, Ning TT, Rong MD*, Rao L*, Ma DD*, 3D-printed bioink loading with stem cells and cellular vesicles for periodontitis-derived bone defect repair, Biofabrication. 2024. (IF=9.0)
3.Zhao Y#, Pan Y#, Zou K#, Lan Z#, Cheng G, Mai Q, Cui H, Meng Q, Chen T, Rao L, Ma L*, Yu GT*. Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy. Bioact Mater. 2023, 19: 237-250. (IF=16.874)
4. Cheng G, Li Z, Liu Y, Ma R, Chen X, Liu W, Song Y, Zhang Y*, Yu G*, Wu Z*, Chen T*. "Swiss Army Knife" black phosphorus-based nanodelivery platform for synergistic antiparkinsonian therapy via remodeling the brain microenvironment, Journal of controlled release 2023, 353: 752-766. (IF=11.467)
5. Cui H#, You Y#, Cheng GW, Lan Z, Zou KL, Mai QY, Han YH, Chen H, Zhao YY*, Yu GT*. Advanced materials and technologies for oral diseases. Sci Technol Adv Mater 2023, 24(1):2156257.(IF=7.662)
6. Lan Z, Zou KL, Cui H, Chen H, Zhao YY*, Yu GT*. PFC@O2 Targets HIF-1a to Reverse the Immunosuppressive TME in OSCC. J Clin Med 2023, 12(2):560.(IF=4.964)
7. Cui H, Lan Z, Zou KL, Zhao YY*, Yu GT*. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma. Cancer immunology, immunotherapy 2022 Nov 27. doi: 10.1007/s00262-022-03336-9.(IF=6.63)
8. Zou KL, Lan Z, Cui H, Zhao YY, Wang WM*, Yu GT*. CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma. Oral Dis 2022.(IF=4.068)
9.Meng QF#, Zhao Y#, Dong C#, Liu L, Pan Y, Lai J, Liu Z, Yu GT*, Chen X*, Rao L*. Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy. Angew Chem Int Ed Engl. 2021, 60(50): 26320-26326. (IF=15.336)
10.Zhao YY, Lian JX, Lan Z, Zou KL, Wang WM, Yu GT*. Ferroptosis promotes anti-tumor immune response by inducing immunogenic exposure in HNSCC. Oral Dis. 2021 Nov 12. doi: 10.1111/odi.14077. （IF=3.511）
11. Wang CY#, Yu GT#, Gao C#, Chen J, Li QL, Zhang L, Wu M*, Sun ZJ*, Li LY*. Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma. Frontiers in molecular biosciences 2021, 8: 701531. (IF=4.188)
12.Yu GT#, Luo MY#, Li H, Chen S, Huang B, Sun ZJ*, Cui R*, Zhang M*. Molecular Targeting Nanoprobes with Non-Overlap Emission in the Second Near-Infrared Window for in Vivo Two-Color Colocalization of Immune Cells. ACS nano 2019, 13(11): 12830-12839. (IF=14.588)
13.Yu GT#, Rao L#, Wu H, Yang LL, Bu LL, Deng WW, Wu L, Nan X, Zhang WF, Zhao XZ, Liu W*, Sun ZJ*. Myeloid-Derived Suppressor Cell Membrane-Coated Magnetic Nanoparticles for Cancer Theranostics by Inducing Macrophage Polarization and Synergizing Immunogenic Cell Death. Advanced Functional Materials 2018, 28(37): 1801389. (IF=15.621)
14.Yu GT#, Mao L#, Wu L, Deng WW, Bu LL, Liu JF, Chen L, Yang LL, Wu H, Zhang WF*, Sun ZJ*. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma. Cellular and molecular life sciences: CMLS 2018, 75(22): 4223-4234. (IF=7.014)
1G.Bu LL#, Yu GT#, Wu L, Mao L, Deng WW, Liu JF, Kulkarni AB, Zhang WF, Zhang L*, Sun ZJ*. STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC. Journal of dental research 2017, 96(9): 1027-1034. (IF=4.755)
16.Yu GT#, Bu LL#, Zhao YY, Mao L, Deng WW, Wu TF, Zhang WF, Sun ZJ. CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma. Oncoimmunology 2016, 5(6): e1151594. (IF=7.644)
17.Bu LL#, Yu GT#, Deng WW, Mao L, Liu JF, Ma SR, Fan TF, Hall B, Kulkarni AB, Zhang WF*, Sun ZJ*. Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma. Oncoimmunology 2016, 5(5): e1130206. (IF=7.644)
18.Yu GT#, Bu LL#, Zhao YY, Liu B, Zhang WF, Zhao YF, Zhang L*, Sun ZJ*. Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma. American journal of cancer research 2014, 4(6): 764-775. (IF=3.968)